【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Spinal Muscular Atrophy (SMA) Overview 9
Therapeutics Development 10
Pipeline Products for Spinal Muscular Atrophy (SMA) – Overview 10
Pipeline Products for Spinal Muscular Atrophy (SMA) – Comparative Analysis 11
Spinal Muscular Atrophy (SMA) – Therapeutics under Development by Companies 12
Spinal Muscular Atrophy (SMA) – Therapeutics under Investigation by Universities/Institutes 15
Spinal Muscular Atrophy (SMA) – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Unknown Stage Products 19
Spinal Muscular Atrophy (SMA) – Products under Development by Companies 20
Spinal Muscular Atrophy (SMA) – Products under Investigation by Universities/Institutes 22
Spinal Muscular Atrophy (SMA) – Companies Involved in Therapeutics Development 23
Bioblast Pharma Ltd. 23
Cellular Biomedicine Group, Inc. 24
Cytokinetics, Inc. 25
F. Hoffmann-La Roche Ltd. 26
Genethon 27
Genzyme Corporation 28
GMP-Orphan SAS 29
Isis Pharmaceuticals, Inc. 30
Longevity Biotech, Inc 31
Neurodyn Inc. 32
Neurotune AG 33
Nexgenix Pharmaceuticals, LLC 34
Novartis AG 35
OrphageniX, Inc. 36
Paratek Pharmaceuticals, Inc. 37
Pfizer Inc. 38
PTC Therapeutics, Inc. 39
Retrophin Inc. 40
Sarepta Therapeutics, Inc. 41
Trophos SA 42
Vybion, Inc. 43
Zambon Company S.p.A. 44
Spinal Muscular Atrophy (SMA) – Therapeutics Assessment 45
Assessment by Monotherapy Products 45
Assessment by Target 46
Assessment by Mechanism of Action 48
Assessment by Route of Administration 50
Assessment by Molecule Type 52
Drug Profiles 54
ALB-111 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Antisense Oligonucleotide for Spinal Muscular Atrophy and Myotonic Dystrophy – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Antisense Oligonucleotide to Inhibit SMN2 gene for SMA – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Antisense Oligonucleotides for Spinal Muscular Atrophy – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
ataluren – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
BBrm-01 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
DNA Oligonucleotides for Spinal Muscular Atrophy – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
Gene Therapy to Activate SMN1 for Spinal Muscular Atrophy – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Gene Therapy to Activate SMN1 for Spinal Muscular Atrophy – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
INT-41 – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
LMI-070 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
ND-602 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
NT-1654 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
nusinersen – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
NXD-30001 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
olesoxime – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Oligonucleotide to Activate SMN2 for Spinal Muscular Atrophy – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
PF-06687859 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
PMO-25 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
PTKSMA-2 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
RE-003 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
RG-7800 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
scAAV9.CB.SMN – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Small Molecules for CNS Disorders – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
sodium phenylbutyrate – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Stem Cell Therapy for Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
Synthetic Peptides for Central Nervous System Disorders and Diabetic Neuropathy – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
tirasemtiv – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
ZP-037 – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
Spinal Muscular Atrophy (SMA) – Recent Pipeline Updates 100
Spinal Muscular Atrophy (SMA) – Dormant Projects 119
Spinal Muscular Atrophy (SMA) – Product Development Milestones 120
Featured News & Press Releases 120
Nov 25, 2014: Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy 120
Nov 17, 2014: Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award 121
Oct 10, 2014: Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With Spinal Muscular Atrophy 122
Oct 02, 2014: Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 125
Oct 02, 2014: AveXis Receives Orphan Drug Status from the US Food and Drug Administration for chariSMA for the Treatment of Spinal Muscular Atrophy 125
Aug 15, 2014: Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 126
Aug 01, 2014: Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 127
Jun 13, 2014: Cytokinetics Announces Data Relating To Tirasemtiv Presented At The 2014 Annual Spinal Muscular Atrophy Conference 127
Jun 06, 2014: Cytokinetics Announces Two Presentations Relating To Tirasemtiv To Be Presented At The 2014 Annual Spinal Muscular Atrophy Conference 129
May 22, 2014: Gene therapy extends survival in an animal model of spinal muscular atrophy 129
Appendix 131
Methodology 131
Coverage 131
Secondary Research 131
Primary Research 131
Expert Panel Validation 131
Contact Us 132
Disclaimer 132
【レポート販売概要】
■ タイトル：脊髄性筋萎縮症(Spinal Muscular Atrophy (SMA))の治療薬パイプライン動向（2015年上半期版）■ 英文：Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6038IDB
■ 調査対象地域：グローバル
- 心拍数モニタリング装置の世界市場2016-2020About Diagnostic Wearable Medical Devices Diagnostic wearable medical devices, used for monitoring, controlling, and tracking an individual's vital signs at regular intervals, have gained momentum in the past few years. These devices measure physiological information through remote or wireless communication and transmit this information to medical professionals or the user. These autonomous, non-i …
- 果物および野菜成分市場の世界市場：濃縮、ペースト・ピューレ、ストレートジュース、固形・粉末The global fruit & vegetable ingredients market is projected to grow at a CAGR of 6.6% from 2015 to reach a value of USD 201.67 Billion by 2020. The market is driven by factors such as increased demand for snacks & convenience food and beverages due to changing consumer preferences. Furthermore, factors such as increasing disposable income and rapid urbanization have also increased the demand for …
- Suncor Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Suncor Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Suncor Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- フォトマスクの世界市場2016-2020Photomasks are high-purity quartz or glass plates that contain a pattern of ICs. These are used in the reproduction of pattern structures for manufacturing printed circuit boards, electronic circuits, and LCD displays, and for the serial production of reticles and other microstructures. Photomasks are used at wavelengths of 365 nm, 248 nm, and 193 nm. ICs are manufactured layer by layer, where eac …
- 金属熱処理の世界市場2016-2020About the Metal Heat Treatment Market Metal heat treatment is a method used to change the physical and chemical properties of metals. Most metal components require thermal processing to change their metallurgical and physical properties to attain the desired engineering requirements for their intended use. Metal heat treatment involves the use of a vacuum furnace in which metals are heated to a pa …
- 使い捨てバイオリアクターの世界市場：波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクターDeveloping markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion’s share of the global SUB market, by molecule type. However, the stem ce …
- 医薬品ラベリングの世界市場2016-2020About the Pharmaceutical Labeling Market Labels are primarily printed pieces of paper, polymer, or film attached to a product, which contains important information about the product and the company. Types of labels available in the market are in-mold labels, pressure-sensitive labels, heat-shrink labels, roll-fed labels, barcode labels, laser labels, and digital labels. The terms packaging and lab …
- アルミホイル包装の世界市場2018-2022112 pages, November 2018 About this market Aluminum is the most preferred packaging material in the food and beverages industry due to its abundance on the earth’s surface and several other valuable properties. Containers made from aluminum foils are recyclable, non-toxic, and resistant to fire. It is also one of the most eco-friendly packaging solutions as recycling of aluminum requires almost 95 …
- 歯科用バイオマテリアルの世界市場予測（～2023年）“The dental biomaterials market is projected to grow at a CAGR of 7.4%.”The global dental biomaterials market is projected to reach USD 9.6 billion by 2023, from USD 6.7 billion in 2018 growing at a CAGR of 7.4% from 2018 to 2023. Factors such as the increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable inc …
- ハイブリッドクラウドの世界市場2019-2023About this market The ability of hybrid clouds to simplify disaster recovery will trigger the hybrid cloud market growth during the forecast period. Hybrid cloud solutions simplify the overall management in a disaster recovery setup. In addition, hybrid cloud model also allows businesses in scaling up their operations up or down as required. Cloud solutions have a very high scalability, in turn, a …
- 窒化ケイ素の世界市場Silicon Nitride (CAS 12033-89-5) Market Research Report 2014 presents comprehensive data on silicon nitride markets globally and regionally (Europe, Asia, North America etc.) The report includes silicon nitride description, covers its application areas and related patterns. It overviews silicon nitride market, names silicon nitride producers and indicates its suppliers. Besides, the report provide …
- 杭打ち機の世界市場分析：製品別（インパクトハンマー、振動ドライバ、リグ）、方法別（インパクト駆動、掘削パーカッシブ、ロータリボーリング、エアリフト逆循環掘削（RCD）、オーガーボーリング、連続フライトオーガー（CFA））、セグメント予測The global piling machine market is expected to reach USD 6.47 billion by 2024, according to a new report by Grand View Research, Inc. The growth of the construction sector in various countries including India, China, Thailand, Saudi Arabia, UAE, Thailand and Malaysia in light of urbanization, population growth, and government infrastructure development initiatives is expected to promote the found …
- スマートカードICの世界市場2016-2020About Smart Card A smart card is made up of PVC, polyester, or polycarbonate and is embedded with an IC, an MCU, and a memory chip. The memory chip is embedded with a smart card IC that can store and process a large amount of data. The microcontroller helps to secure payment transactions with functions such as encryption and digital signatures. It provides a tamper-resistant system and protects in …
- 商用車用遠隔診療の世界市場2017-2021About Commercial Vehicle Remote DiagnosticsTechnavio defines automotive remote diagnostics or remote vehicle diagnostics as a solution that enables automation of vehicle health and diagnosis using a wireless network. Vehicle health check refers to monitoring vehicle performance by continuously checking and assessing real-time data of certain parameters. This process helps to identify any deviation …
- 構内配線の世界市場2019-2023About this market Integrated building management system to drive market growth. An integrated building management system (BMS) is a type of master control system that combines every mechanical, electrical, security, and communication systems within a facility into a single unified system. This enables them to exchange information with each other and work together seamlessly. Such a system makes th …
